Prostate Cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age equal to or greater than 18 years and less than 90 years at the time of signing informed consent. 2. Patients who are candidates for prostate puncture because of elevated PSA, or positive digital rectal examination, or imaging findings suggestive of suspected prostate cancer; Or patients with pathologic diagnosis of prostate cancer by puncture / surgery. 3. Expected survival > 12 months 4. ECoG score 0-2 points 5. Patient consent and ability to follow the planned study visit, provide blood, urine and surgical samples for the specified period of treatment, may provide clinical information and cooperate with other study steps 6. Patients had normal organ function with WBC = 3000 / mm3 or absolute neutrophil count = 1500 / mm3 and AST and ALT below 1.5 ULN.
Exclusion criteria
Exclusion criteria: 1. The investigator judged that the patient had other serious illnesses that could affect follow-up and short-term survival, and any medical cause that showed a significant risk of death during the 1-year study period 2. Had any other malignancy within 3 years prior to enrollment 3. Clinical information required for the study was not available. 4. Situations in which enrollment was not considered appropriate by the other investigators
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Multiomics features of blood;Multiomics features of urine;Multiomics features of histopathology;Features of clinicopathological information; | — |
Countries
CHINA
Contacts
Xiangya Hospital of Central South University, No. 87 Xiangya Road, Kaifu District, Changsha, Hunan Province